Furthermore, it has been demonstrated that the expression of VEGFR-1 in cancer cells could determine the efficacy of anti-PlGF treatment, a hypothesis that was suggested as a possible explanation for the conflicting data in the literature [12]. The gene discussed is PGF; the disease is cancer.